Drug class
Non-nitrate nitric oxide donor; antianginal vasodilator
Mechanism of action
Molsidomine is converted to the active metabolite SIN-1, which releases nitric oxide. Nitric oxide activates soluble guanylate cyclase, increasing cyclic GMP in vascular smooth muscle and causing vasodilation; it also reduces platelet aggregation.
General use cases
- Prevention and long-term treatment of angina pectoris and chronic coronary heart disease where authorised; it is not intended for immediate relief of an acute angina attack.
For general informational purposes only. Do not rely on, cross-reference, cite or use this information as evidence or support for legal, regulatory, commercial or other claims.
